(Q41343573)
Statements
Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility (English)
H H Lee
W R Wilson
P B Roberts